Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Breast Cancer | Unmet Need | Metastatic Triple-Negative Breast Cancer | US/EU | 2019
Triple-negative breast cancer (TNBC) is a patient population with high unmet need given the poor outcomes associated with current treatment options and the historic lack of targeted therapies…
Gram-Negative Infections | Unmet Need | HABP/VABP Gram-Negative Infections | US/EU | 2019
MARKET OUTLOOK Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are among the most common and serious infections in the hospital setting. HABP/…
Atopic Dermatitis / Atopic Eczema – Unmet Need – Unmet Need – Atopic Dermatitis/Atopic Eczema (Pediatric) (US/EU)
The management of pediatric patients with moderate to severe atopic dermatitis (AD) is poised for transformation. Sanofi/Regeneron’s Dupixent, on the heels of a positive Phase III study in…